Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease

被引:4
|
作者
Santos-Garcia, Diego [1 ]
de Deus, Teresa [1 ]
Lopez-Pazos, Elina [1 ]
Macias-Arribi, Mercedes [1 ]
Llaneza-Gonzalez, Miguel A. [1 ]
Echarri-Piudo, Ana [2 ]
Carpintero, Pedro [2 ]
de la Fuente-Fernandez, Raul [1 ]
机构
[1] Complexo Hosp Univ Ferrol, Hosp Arquitecto Marcide, Secc Neurol, Ferrol, A Coruna, Spain
[2] Complexo Hosp Univ Ferrol, Hosp Arquitecto Marcide, Secc Digest, Ferrol, A Coruna, Spain
关键词
Complications; Granuloma; Intraduodenal continuous levodopa/carbidopa infusion; Levodopa; Parkinson's disease; Percutaneous endoscopic gastrostomy; DUODENAL LEVODOPA INFUSION; CARBIDOPA INTESTINAL GEL; PERIPHERAL NEUROPATHY; DUODOPA; THERAPY; IMPROVEMENT; EXPOSURE; EFFICACY;
D O I
10.33588/rn.5811.2014067
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Continuous infusion of intraduodenal levodopa/carbidopa is an effective treatment that improves the motor complications and the quality of life of patients in the advanced stages of Parkinson's disease. However, it is not free of complications. These may present in the post-operative period following surgery (gastrostomy) or in the long-term during the follow-up period and can be related with the medication (levodopa/carbidopa), the stoma, the gastrostomy or the device (pump, enteral tube, parts of the FREKA system). The aim of this review is to report on the management of the complications that can be observed in patients with advanced Parkinson's disease treated with continuous infusion of intraduodenal levodopa/carbidopa.
引用
收藏
页码:505 / 515
页数:11
相关论文
共 50 条
  • [1] Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease
    Fernandez-Pajarin, Gustavo
    Ares-Pensado, Begona
    Sesar, Angel
    Iglesias-Canle, Jose
    Masa-Vazquez, Luis
    Castro, Alfonso
    REVISTA DE NEUROLOGIA, 2018, 67 (01) : 1 - 5
  • [2] Intraduodenal levodopa infusion and blood pressure in patients with advanced Parkinson's disease
    Pursiainen, V.
    Pekkonen, E.
    MOVEMENT DISORDERS, 2010, 25 (07) : S334 - S334
  • [3] Effects of intraduodenal levodopa infusion therapy on Parkinson's disease
    Tomantschger, V.
    Tautscher-Basnett, G.
    Freimueller, M.
    MOVEMENT DISORDERS, 2010, 25 (07) : S431 - S431
  • [4] Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa
    Santos Garcia, Diego
    Martinez Castrillo, Juan Carlos
    Puente Periz, Vctor
    Seoane Urgorri, Agustin
    Fernandez Diez, Servando
    Benita Leon, Vicente
    Udaeta Baldivieso, Beatriz
    Campolongo Perillo, Antonia
    Mariscal Perez, Natividad
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (03) : 187 - 202
  • [5] Intraduodenal infusion of a gel suspension of levodopa/carbidopa, Duodopa®, in advanced Parkinson's disease:: Safety, tolerability, efficacy and dosage
    Nyholm, D
    Lewander, T
    Johansson, A
    LeWitt, PA
    Lundqvist, C
    Aquilonius, SM
    MOVEMENT DISORDERS, 2004, 19 : S177 - S177
  • [6] Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease
    Moes, Harmen R.
    Buskens, Erik
    van Laar, Teus
    LANCET NEUROLOGY, 2024, 23 (09): : 856 - 857
  • [7] Complications of percutaneous endoscopic gastrostomy-jejunostomy for levodopa/carbidopa infusion in advanced Parkinson's disease
    Olivares, Ana
    Collado, David
    Munoz-Navas, Miguel
    Calvo, Marta
    Olivo, Eduardo
    Chico, Inmaculada
    Marra, Carlos
    Sanchez-Estella, Rafael
    Rodriguez, Sarbelio
    Subtil, Jose Carlos
    Rabago, Luis Ramon
    GASTROENTEROLOGY INSIGHTS, 2012, 4 (01) : 13 - 15
  • [8] Complications of gastrojejunostomy in patients with Parkinson's disease on levodopa/carbidopa intestinal gel treatment
    Straka, I.
    Gmitterova, K.
    Juricek, R.
    Stevove, M.
    Stankova, S.
    Filkasz, E.
    Valkovic, P.
    Minar, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 716 - 716
  • [9] Levodopa/carbidopa intestinal gel for pain related to levodopa-induced motor complications in Parkinson’s disease
    Domiziana Rinaldi
    Lanfranco De Carolis
    Francesco Ceriello
    Edoardo Bianchini
    Francesco E. Pontieri
    Neurological Sciences, 2022, 43 : 4571 - 4572
  • [10] Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease
    Nilsson, D
    Hansson, LE
    Johansson, K
    Nystrom, C
    Paalzow, L
    Aquilonius, SM
    ACTA NEUROLOGICA SCANDINAVICA, 1998, 97 (03): : 175 - 183